Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

The objective of this study was to evaluate the pharmacokinetics of indinavir in human immunodeficiency virus-infected children as part of a prospective, open, uncontrolled, multicenter study in The Netherlands. Human immunodeficiency virus type 1-infected children were monitored over 6 months of tr...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Foilsithe in:	Antimicrob Agents Chemother
Príomhchruthaitheoirí:	Burger, David M., van Rossum, Annemarie M. C., Hugen, Patricia W. H., Suur, Marja H., Hartwig, Nico G., Geelen, Sibyl P. M., Scherpbier, Henriette J., Hoetelmans, Richard M. W., Vulto, Arnold G., de Groot, Ronald
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	American Society for Microbiology (ASM) 2001
Ábhair:	Pharmacology
Rochtain ar líne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90359/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.701-705.2001
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

Míreanna comhchosúla